IP Library Granted Patent US 8,110,660
Granted Patent B2
US 8,110,660 · App. 11/719,730 · Granted Feb 7, 2012

Soluble ENPP4 protein

Assignee: Ono Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,110,660
App. No.
11/719,730
Granted
Feb 7, 2012
Kind
B2
Abstract

The present invention relates to a method for screening a medicine using a protein, and a compound obtained by the screening method. A compound or a salt thereof inhibiting activity or expression of the protein of the present invention, a neutralizing antibody against the protein, a polynucleotide that are complementary to a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating neurodegenerative diseases and the like. Moreover, a compound or a salt thereof enhancing activity or expression of the protein of the present invention, the protein or a partial peptide thereof, a polynucleotide coding the protein, and the like can be used as an agent for preventing and/or treating cancers and the like. Furthermore, the protein of the present invention is useful as a reagent for screening a compound inhibiting or enhancing activity of the protein.

Claims (2)

1. An isolated protein consisting of the amino acid sequence of SEQ ID NO: 7.

2. An isolated protein consisting of the amino acid sequence of SEQ ID NO: 28.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2007
From: TADA, HIDEAKI; BANDO, TOMOYUKI; HAYASHI, AKIO
To: ONO PHARMACEUTICAL CO., LTD.
Reel/Frame 019315/0394 →
Priority Claims (1)
JP 2004-336732 · Nov 19, 2004 · national
Continuity (1)
Related Publication 20100240583A1 · Sep 23, 2010